Use of a novel cross-linking method to modify adenovirus tropism

Gene Therapy

Volumn 4, Issue 12, 1997, Pages 1387-1392

  Rogers, B E ^a,b   Douglas, J T ^a   Ahlem, C ^c   Buchsbaum, D J ^b   Frincke, J ^c   Curiel, D T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b The University of Alabama at Birmingham   (United States)

^c Prolinx Biochemistry   (United States)

Author keywords

Adenovirus; Basic fibroblast growth factor; Chemical cross linking; Gene transfer; Tropism modification

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; LUCIFERASE; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; CROSS LINKING; EXPRESSION VECTOR; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TECHNIQUE; TUMOR CELL LINE; VIRUS RECOMBINANT;

ADENOVIRIDAE;

EID: 0031453132     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300541     Document Type: Article

References (19)

1. Roth JA, Cristiano RJ. Gene therapy for cancer - what have we done and where are we going (review). J Natl Cancer Inst 1997; 89: 21-39.
2. Wickham TJ et al. Targeted adenovirus gene transfer to endothehal and smooth muscle cells by using bispecific antibodies. J Virol 1996; 70: 6831-6838.
3. Wickham TJ, Roelvmk PW, Brough DE, Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotech 1996; 14: 1570-1573.
4. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839-6846.
5. Douglas JT et al. Targeted gene delivery by rropism-modined adenoviral vectors. Nature Biotech 1996; 14: 1574-1578.
6. Goldman CK et al. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res 1997; 57: 1447-1451.
7. Rogers BE et al. Enhanced m vivo gene delivery utilizing tropism-modified adenovirus vectors J Virol 1997 (submitted)
8. Lappi DA, Matsunami R, Martineau D, Baird A. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin. Anal Biochem 1993; 212: 446-451.
9. Baird A, Klagsbrun M. The fibroblast growth factor family. Cancer Cells 1991; 3: 239-243.
10. Lappi DA et al. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J Biol Chem 1994; 269: 12552-12558.
11. Casscells W et al. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci USA 1992; 89: 7159-7163.
12. Ying W et al. Anti-Bl6-Fl0 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin. Cancer 1994; 74: 848-853.
13. Beitz JG et al. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res 1992; 52: 227-230.
14. Behar CF et al. Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro. Invest Ophthalmol Vis Sci 1995; 36: 2425-2433.
15. Sosnowski BA et al. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J Biol Chem 1996; 271: 33647-33653.
16. Graham F, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, Walker JM (eds). Methods in Molecular Biology, Vol 7. Gene Transfer and Expression Techniques. Humana Press: Clifton, 1991, pp 109-128.
17. Giard DJ et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973; 51: 1417-1423.
18. Bigner SH et al. Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice. J Neuropathol Exp Neurol 1981; 40: 390-409.
19. Goldman CK et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993; 4: 121-133.